论文部分内容阅读
由于乙型肝炎的标志—乙型肝炎表面抗原(以下简称HBsAg)的发现,人们对乙型肝炎和原发性肝癌(以后简称肝癌)关系的重视,以及对肝癌患者作的手术治疗,使我们有机会累积了13例肝癌的临床、化验、病理和免疫状态等各方面的资料。这样,对肝癌的病因探讨,提供了一些间接的客观依据。本文初步证实了乙型肝炎的标志-HBsAg、肝硬变和肝癌的关系十分密切,说明乙型肝炎抗原血症和肝癌之间可能有某种内在的联系。据此,我们认为乙型肝炎病毒可能是持续性感染肝细胞中的一种致癌原或-辅致癌原。但由于病例不多,上述看法必然带有局限性和不正确。
Due to the discovery of Hepatitis B surface antigen (hereinafter referred to as HBsAg), the sign of Hepatitis B, people pay more attention to the relationship between Hepatitis B and primary hepatocellular carcinoma (hereinafter referred to as hepatocellular carcinoma) and the surgical treatment of patients with liver cancer, Have the opportunity to accumulate 13 cases of liver cancer clinical, laboratory, pathology and immune status and other aspects of the information. In this way, the etiology of liver cancer provides some indirect basis for the objective. This article preliminary confirmed the signs of hepatitis B - HBsAg, cirrhosis and liver cancer are closely related, indicating that hepatitis B antigenic disease and liver cancer may have some intrinsic link between. Accordingly, we believe that Hepatitis B virus may be an oncogenic or - accessory carcinogen in a persistent infection of hepatocytes. However, due to the small number of cases, the above view inevitably has limitations and is not correct.